ATALAR, F. Et Al. FLT3-Receptor Thyrosine Kinase Activation Mediates Its Leukomogenic Effect Through WNT Signaling Pathway in AML patients. 30th World Congress of the International Society of Hematology , (İstanbul, Turkey), 195.

ATALAR, F., SAYİTOĞLU, M., HATIRNAZ, O., & ÖZBEK, U., FLT3-Receptor Thyrosine Kinase Activation Mediates Its Leukomogenic Effect Through WNT Signaling Pathway in AML patients . 30th World Congress of the International Society of Hematology (pp.195). İstanbul, Turkey

ATALAR, FATMAHAN Et Al. "FLT3-Receptor Thyrosine Kinase Activation Mediates Its Leukomogenic Effect Through WNT Signaling Pathway in AML patients," 30th World Congress of the International Society of Hematology, İstanbul, Turkey,

ATALAR, FATMAHAN Et Al. "FLT3-Receptor Thyrosine Kinase Activation Mediates Its Leukomogenic Effect Through WNT Signaling Pathway in AML patients." 30th World Congress of the International Society of Hematology , İstanbul, Turkey, pp.195

ATALAR, F. Et Al. . "FLT3-Receptor Thyrosine Kinase Activation Mediates Its Leukomogenic Effect Through WNT Signaling Pathway in AML patients." 30th World Congress of the International Society of Hematology , İstanbul, Turkey, p.195.

@conferencepaper{conferencepaper, author={FATMAHAN ATALAR Et Al. }, title={FLT3-Receptor Thyrosine Kinase Activation Mediates Its Leukomogenic Effect Through WNT Signaling Pathway in AML patients}, congress name={30th World Congress of the International Society of Hematology}, city={İstanbul}, country={Turkey}, year={0}, pages={195} }